Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome

Journal of Steroid Biochemistry and Molecular Biology

Volumn 175, Issue , 2018, Pages 177-189

  Wimalawansa, Sunil J ^a  

^a Cardio Metabolic Institute   (United States)

Author keywords

1,25(OH)2D; 25(OH) D; Bariatric surgery; Cardiovascular; Complications; Hypertension; Insulin; Morbidity and mortality; Premature death

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; VITAMIN D RECEPTOR; CALCITRIOL;

ADOLESCENT; ADULT; AGED; AUTOIMMUNITY; BARIATRIC SURGERY; CALCIUM HOMEOSTASIS; CELL MEMBRANE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; SAFETY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CLINICAL TRIAL (TOPIC); MALE; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

CALCITRIOL; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; METABOLIC SYNDROME; MUSCLE, SKELETAL; OBESITY; POLYCYSTIC OVARY SYNDROME; PREDIABETIC STATE; VITAMIN D DEFICIENCY;

EID: 85000838113     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.09.017     Document Type: Review

References (218)

1. Suzuki, T., Kwon, J., Kim, H., Shimada, H., Yoshida, Y., Iwasa, H., et al. Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J. Bone Miner. Res. 23:8 (2008), 1309–1317.
2. Harju, E., Sotaniemi, E., Puranen, J., Lahti, R., High incidence of low serum vitamin D concentration in patients with hip fracture. Arch. Orthop. Trauma Surg. 103:6 (1985), 408–416.
3. Laird, E., Ward, M., McSorley, E., Strain, J.J., Wallace, J., Vitamin D and bone health: potential mechanisms. Nutrients 2:7 (2010), 693–724.
4. Khazai, N., Judd, S.E., Tangpricha, V., Calcium and vitamin D: skeletal and extraskeletal health. Curr. Rheumatol. Rep. 10:2 (2008), 110–117.
5. Perez-Lopez, F.R., Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58:2 (2007), 117–137.
6. Bruce, D.G., St John, A., Nicklason, F., Goldswain, P.R., Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J. Am. Geriatr. Soc. 47:3 (1999), 354–359.
7. Wimalawansa, S.J., Vitamin D: An essential component for skeletal health. Ann. NYAS 1240:1 (2012), 90–98.
8. Wimalawansa, S.J., Vitamin D in the new millennium. Curr. Osteoporos. Rep. 10:1 (2012), 4–15.
9. Wimalawansa, S.J., Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes, and future metabolic complications. J. Diab. Metab. Disord. Control 3:1 (2016), 1–10.
10. McCarty, M.F., Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med. Hypotheses 72:6 (2009), 647–651.
11. Wimalawansa, S.J., Vitamin D: Everything You Need to Know. 2012, Karunaratne & Sons, Homagama, Sri Lanka 978-955-9098-94-2.
12. Khor, G.L., Chee, W.S., Shariff, Z.M., Poh, B.K., Arumugam, M., Rahman, J.A., et al. High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia. BMC Public Health, 11, 2011, 95.
13. Nashimoto, M., Nakamura, K., Matsuyama, S., Hatakeyama, M., Yamamoto, M., Hypovitaminosis D and hyperparathyroidism in physically inactive elderly Japanese living in nursing homes: relationship with age, sunlight exposure and activities of daily living. Aging Clin. Exp. Res. 14:1 (2002), 5–12.
14. Vanlint, S., Nugent, M., Durvasula, S., Vitamin D and people with intellectual disability. Aust. Fam. Physician 37:5 (2008), 348–351.
15. Parker, J.H.O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.B., Clarke, A., Franco, O.H., Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65 (2010), 225–236.
16. Poolsup, N., Suksomboon, N., Plordplong, N., Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet. Med. 33:3 (2016), 290–299.
17. George, P.S., Pearson, E.R., Witham, M.D., Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. 29:8 (2012), e142–50.
18. Manousopoulou, A., Al-Daghri, N.M., Garbis, S.D., Chrousos, G.P., Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur. J. Clin. Invest. 45:10 (2015), 1113–1126.
19. Pilz, S., Kienreich, K., Rutters, F., de Jongh, R., van Ballegooijen, A.J., Grubler, M., et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr. Diab. Rep. 13:2 (2013), 261–270.
20. Sung, C.C., Liao, M.T., Lu, K.C., Wu, C.C., Role of vitamin D in insulin resistance. J. Biomed. Biotechnol., 2012, 2012, 634195.
21. Binkley, N., Krueger, D., Evaluation and correction of low vitamin D status. Curr. Osteoporos. Rep. 6:3 (2008), 95–99.
22. Heaney, R.P., Davies, K.M., Chen, T.C., Holick, M.F., Barger-Lux, M.J., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77:1 (2003), 204–210.
23. Vieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69:5 (1999), 842–856.
24. Garland, C.F., French, C.B., Baggerly, L.L., Heaney, R.P., Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 31:2 (2011), 607–611.
25. Lowe, H., Cusano, N.E., Binkley, N., Blaner, W.S., Bilezikian, J.P., Vitamin D toxicity due to a commonly available over the counter remedy from the Dominican Republic. J. Clin. Endocrinol. Metab. 96:2 (2011), 291–295.
26. Binkley, N., Lewiecki, E.M., Vitamin D and common sense. J. Clin. Densitom. 14:2 (2011), 95–99.
27. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96:7 (2011), 1911–1930.
28. Grant, W.B., Wimalawansa, S.J., Holick, M.F., Cannell, J.J., Pludowski, P., Lappe, J.M., et al. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients 7:3 (2015), 1538–1564.
29. Wimalawansa, S.J., Vitamin D: biology, physiology, and pathology. J. Diab. Treat., 2016 in press.
30. Wimalawansa, S.J., Vitamin D adequacy and improvements of comorbidities in persons with intellectual developmental disabilities. J. Child. Dev. Disord. 2:3 (2016), 22–33.
31. Grant, W.B., Wimalawansa, S.J., Holick, M.F., Vitamin D supplements and reasonable solar UVB should be recommended to prevent escalating incidence of chronic diseases. Br. Med. J., 350, 2015, h321.
32. Hollis, B.W., Wagner, C.L., Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98:12 (2013), 4619–4628.
33. Mosekilde, L., Vitamin D and the elderly. Clin. Endocrinol. (Oxf.) 62:3 (2005), 265–281.
34. Moyad, M.A., The potential benefits of dietary and/or supplemental calcium and vitamin D. Urol. Oncol. 21:5 (2003), 384–391.
35. Wimalawansa, S.J., Vitamin D; what clinicians would like to know. Sri Lanka J. Diab. Endocrinol. Metab. 1:2 (2012), 73–88.
36. Hollis, B.W., Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135:2 (2005), 317–322.
37. Pittas, A.G., Nelson, J., Mitri, J., Hillmann, W., Garganta, C., Nathan, D.M., et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diab. Care 35:3 (2012), 565–573.
38. Lappe, J.M., Heaney, R.P., Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinology 4:2 (2012), 95–100.
39. Eggemoen, A.R., Knutsen, K.V., Dalen, I., Jenum, A.K., Vitamin D status in recently arrived immigrants from Africa and Asia: a cross-sectional study from Norway of children, adolescents and adults. BMJ Open, 3(10), 2013, e003293.
40. Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20:11 (2009), 1807–1820.
41. van Schoor, N.M., Lips, P., Worldwide vitamin d status. Best Pract. Res. Clin. Endocrinol. Metab. 25:4 (2011), 671–680.
42. Datta, S., Alfaham, M., Davies, D.P., Dunstan, F., Woodhead, S., Evans, J., et al. Vitamin D deficiency in pregnant women from a non-European ethnic minority population–an interventional study. BJOG 109:8 (2002), 905–908.
43. Chailurkit, L-o., Aekplakorn, W., Ongphiphadhanakul, B., Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health 11:1 (2011), 1–7.
44. Chailurkit, L.O., Kruavit, A., Rajatanavin, R., Vitamin D status and bone health in healthy Thai elderly women. Nutrition 27:2 (2011), 160–164.
45. Hanieh, S., Ha, T.T., Simpson, J.A., Thuy, T.T., Khuong, N.C., Thoang, D.D., et al. Maternal vitamin D status and infant outcomes in rural Vietnam: a prospective cohort study. PLoS One, 9(6), 2014, e99005.
46. Abiaka, C., Delghandi, M., Kaur, M., Al-Saleh, M., Vitamin D status and anthropometric indices of an Omani study population. Sultan Qaboos Univ. Med. J. 13:2 (2013), 224–231.
47. von Hurst, P.R., Stonehouse, W., Coad, J., Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient − a randomised, placebo-controlled trial. Br. J. Nutr. 103:4 (2010), 549–555.
48. Poole, K.E., Loveridge, N., Barker, P.J., Halsall, D.J., Rose, C., Reeve, J., et al. Reduced vitamin D in acute stroke. Stroke 37:1 (2006), 243–245.
49. Scragg, R., Jackson, R., Holdaway, I.M., Lim, T., Beaglehole, R., Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int. J. Epidemiol. 19:3 (1990), 559–563.
50. Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R., Stehle, P., Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J. Am. Coll. Cardiol. 41:1 (2003), 105–112.
51. Cigolini, M., Iagulli, M.P., Miconi, V., Galiotto, M., Lombardi, S., Targher, G., Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diab. Care 29:3 (2006), 722–724.
52. Sacheck, J., Goodman, E., Chui, K., Chomitz, V., Must, A., Economos, C., Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J. Pediatr. 159:6 (2011), 945–950.
53. Camargo, C.A. Jr., Vitamin D and cardiovascular disease: time for large randomized trials. J. Am. Coll. Cardiol. 58:14 (2011), 1442–1444.
54. Maki, K.C., Rubin, M.R., Wong, L.G., McManus, J.F., Jensen, C.D., Lawless, A., Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int. J. Food Sci. Nutr. 62:4 (2011), 318–327.
55. O'Keefe, J.H., Lavie, C.J., Holick, M.F., Vitamin D supplementation for cardiovascular disease prevention. JAMA 306:14 (2011), 1546–1547 author reply 7–8.
56. Vacek, J.L., Vanga, S.R., Good, M., Lai, S.M., Lakkireddy, D., Howard, P.A., Vitamin D deficiency and supplementation and relation to cardiovascular health. Am. J. Cardiol. 109:3 (2012), 359–363.
57. Anagnostis, P., Athyros, V.G., Adamidou, F., Florentin, M., Karagiannis, A., Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr. Vasc. Pharmacol. 8:5 (2010), 720–730.
58. Souberbielle, J.C., Body, J.J., Lappe, J.M., Plebani, M., Shoenfeld, Y., Wang, T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 9:11 (2010), 709–715.
59. Van der Schueren, B.J., Verstuyf, A., Mathieu, C., Straight from D-Heart: vitamin D status and cardiovascular disease. Curr. Opin. Lipidol. 23:1 (2012), 17–23.
60. Greenspan, S.L., Resnick, N.M., Parker, R.A., Vitamin D supplementation in older women. J. Gerontol. A. Biol. Sci. Med. Sci. 60:6 (2005), 754–759.
61. Gonzalez-Molero, I., Rojo-Martinez, G., Morcillo, S., Gutierrez-Repiso, C., Rubio-Martin, E., Almaraz, M.C., et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin. Nutr. 31:4 (2012), 571–573.
62. Chirita-Emandi, A., Socolov, D., Haivas, C., Calapis, A., Gheorghiu, C., Puiu, M., Vitamin D status: a different story in the very young versus the very old Romanian patients. PLoS One, 10(5), 2015, e0128010.
63. Kruavit, A., Chailurkit, L.O., Thakkinstian, A., Sriphrapradang, C., Rajatanavin, R., Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents. BMC Geriatr., 12, 2012, 49.
64. Hagenau, T., Vest, R., Gissel, T.N., Poulsen, C.S., Erlandsen, M., Mosekilde, L., et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos. Int. 20:1 (2009), 133–140.
65. Saneei, P., Salehi-Abargouei, A., Esmaillzadeh, A., Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes. Rev. 14:5 (2013), 393–404.
66. Bhattoa, H.P., Bettembuk, P., Ganacharya, S., Balogh, A., Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos. Int. 15:6 (2004), 447–451.
67. Porojnicu, A.C., Robsahm, T.E., Dahlback, A., Berg, J.P., Christiani, D., Bruland, O.S., et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role?. Lung Cancer 55:3 (2007), 263–270.
68. Nurmi, I., Kaukonen, J.P., Luthje, P., Naboulsi, H., Tanninen, S., Kataja, M., et al. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos. Int. 16:12 (2005), 2018–2024.
69. Arantes, H.P., Kulak, C.A., Fernandes, C.E., Zerbini, C., Bandeira, F., Barbosa, I.C., et al. Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial. Osteoporos. Int. 24:10 (2013), 2707–2712.
70. Grant, W.B., Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res. 32:1 (2012), 223–236.
71. Zittermann, A., Schleithoff, S.S., Koerfer, R., Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94:4 (2005), 483–492.
72. Grimes, D.S., Hindle, E., Dyer, T., Sunlight, cholesterol and coronary heart disease. QJM 89:8 (1996), 579–589.
73. Rostand, S.G., Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30 (1979), 150–156.
74. Mathieu, C., Vitamin D and diabetes: where do we stand?. Diab. Res. Clin. Pract. 108:2 (2015), 201–209.
75. Van Belle, T.L., Gysemans, C., Mathieu, C., Vitamin D and diabetes: the odd couple. Trends Endocrinol. Metab. 24:11 (2013), 561–568.
76. Zipitis, C., Akobeng, A.K., Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93:6 (2008), 512–517.
77. Tsur, A., Feldman, B.S., Feldhammer, I., Hoshen, M.B., Leibowitz, G., Balicer, R.D., Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diab. Care 36:5 (2013), 1361–1367.
78. Pani, M.A., Regulla, K., Segni, M., Krause, M., Hofmann, S., Hufner, M., et al. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves’ disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur. J. Endocrinol. 146:6 (2002), 777–781.
79. Holick, M.F., Vitamin D: a D-lightful health perspective. Nutr. Rev. 66:Suppl. 2 (2008), S182–S194 10.
80. LaCroix, A.Z., Kotchen, J., Anderson, G., Brzyski, R., Cauley, J.A., Cummings, S.R., et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci. 64:5 (2009), 559–567.
81. Khan, H., Kunutsor, S., Franco, O.H., Chowdhury, R., Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc. Nutr. Soc. 72:1 (2013), 89–97.
82. Takiishi, T., Gysemans, C., Bouillon, R., Mathieu, C., Vitamin D and diabetes. Rheum. Dis. Clin. North Am. 38:1 (2012), 179–206.
83. Afzal, S., Bojesen, S.E., Nordestgaard, B.G., Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin. Chem. 59:2 (2013), 381–391.
84. Mitri, J., Muraru, M.D., Pittas, A.G., Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65:9 (2011), 1005–1015.
85. Shab-Bidar, S., Neyestani, T.R., Djazayery, A., Vitamin D receptor Cdx-2-dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial. Br. J. Nutr. 114:9 (2015), 1375–1384.
86. Nasri, H., Behradmanesh, S., Ahmadi, A., Rafieian-Kopaei, M., Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J. Nephropathol. 3:1 (2014), 29–33.
87. Khadgawat, R., Thomas, T., Gahlot, M., Tandon, N., Tangpricha, V., Khandelwal, D., et al. The effect of puberty on interaction between Vitamin D status and insulin resistance in obese asian-Indian children. Int. J. Endocrinol., 2012, 2012, 173581.
88. Roth, C.L., Elfers, C., Kratz, M., Hoofnagle, A.N., Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines. J. Obes., 2011, 2011, 495101.
89. Heaney, R.P., Health is better at serum 25(OH)D above 30 ng/mL. J. Steroid Biochem. Mol. Biol. 136 (2013), 224–228.
90. Tepper, S., Shahar, D.R., Geva, D., Ish-Shalom, S., Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial. Diab. Obes. Metab. 18:6 (2016), 633–637.
91. Cheng, Q., Boucher, B.J., Leung, P.S., Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice. Diabetologia 56:3 (2013), 553–562.
92. Belenchia, A.M., Tosh, A.K., Hillman, L.S., Peterson, C.A., Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am. J. Clin. Nutr. 97 (2013), 774–781.
93. Larsen, T., Mose, F.H., Bech, J.N., Hansen, A.B., Pedersen, E.B., Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25:11 (2012), 1215–1222.
94. Pilz, S., Kienreich, K., Tomaschitz, A., Ritz, E., Lerchbaum, E., Obermayer-Pietsch, B., et al. Vitamin d and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med. Chem. 13:1 (2013), 107–117.
95. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:9736 (2010), 180–188.
96. Wang, X.F., Deng, X.L., Wang, N.P., Roles of vitamin D in cardiovascular diseases. Sheng Li Ke Xue Jin Zhan 44:3 (2013), 223–226.
97. Grant, W.B., An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur. J. Clin. Nutr. 65:9 (2011), 1016–1026.
98. Daly, R.M., Nowson, C.A., Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. Eur. J. Clin. Nutr. 63:8 (2009), 993–1000.
99. Wimalawansa, S.J., Antihypertensive effects of oral calcium supplementation may be mediated through the potent vasodilator CGRP. Am. J. Hypertens. 6:12 (1993), 996–1002.
100. Halliday, T.M., Peterson, N.J., Thomas, J.J., Kleppinger, K., Hollis, B.W., Larson-Meyer, D.E., Vitamin D status relative to diet, lifestyle, injury, and illness in college athletes. Med. Sci. Sports Exerc. 43:2 (2011), 335–343.
101. Tangpricha, V., Turner, A., Spina, C., Decastro, S., Chen, T.C., Holick, M.F., Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am. J. Clin. Nutr. 80:6 (2004), 1645–1649.
102. Pacifico, L., Anania, C., Osborn, J.F., Ferraro, F., Bonci, E., Olivero, E., et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur. J. Endocrinol. 165:4 (2011), 603–611.
103. Dandona, P., Aljada, A., Bandyopadhyay, A., Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25:1 (2004), 4–7.
104. Dandona, P., Aljada, A., Chaudhuri, A., Bandyopadhyay, A., The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J. Clin. Endocrinol. Metab. 88:6 (2003), 2422–2429.
105. Krishnan, A.V., Feldman, D., Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin d. Annu. Rev. Pharmacol. Toxicol. 51 (2011), 311–336.
106. Adorini, L., Amuchastegui, S., Corsiero, E., Laverny, G., Le Meur, T., Penna, G., Vitamin D receptor agonists as anti-inflammatory agents. Expert Rev. Clin. Immunol. 3:4 (2007), 477–489.
107. Neyestani, T.R., Nikooyeh, B., Alavi-Majd, H., Shariatzadeh, N., Kalayi, A., Tayebinejad, N., et al. Improvement of Vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J. Clin. Endocrinol. Metab., 2012.
108. Chagas, C.E., Borges, M.C., Martini, L.A., Rogero, M.M., Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4:1 (2012), 52–67.
109. Choi, H.S., Kim, K.A., Lim, C.Y., Rhee, S.Y., Hwang, Y.C., Kim, K.M., et al. Low serum vitamin D is associated with high risk of diabetes in Korean adults. J. Nutr. 141:8 (2011), 1524–1528.
110. Gupta, A.K., Brashear, M.M., Johnson, W.D., Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diab. Care 34:3 (2011), 658–660.
111. Hamed, E.A., Abu Faddan, N.H., Adb Elhafeez, H.A., Sayed, D., Parathormone − 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr. Diab. 12:6 (2011), 536–546.
112. Littorin, B., Blom, P., Scholin, A., Arnqvist, H.J., Blohme, G., Bolinder, J., et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49:12 (2006), 2847–2852.
113. Oh, J., Weng, S., Felton, S.K., Bhandare, S., Riek, A., Butler, B., et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120:8 (2009), 687–698.
114. Palomer, X., Gonzalez-Clemente, J.M., Blanco-Vaca, F., Mauricio, D., Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diab. Obes. Metab. 10:3 (2008), 185–197.
115. Peechakara, S.V., Pittas, A.G., Vitamin D as a potential modifier of diabetes risk. Nat. Clin. Pract. Endocrinol. Metab. 4:4 (2008), 182–183.
116. Di Cesar, D.J., Ploutz-Snyder, R., Weinstock, R.S., Moses, A.M., Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diab. Care, 29(1), 2006, 174.
117. Mathieu, C., Badenhoop, K., Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol. Metab. 16:6 (2005), 261–266.
118. Lagunova, Z., Porojnicu, A.C., Lindberg, F.A., Aksnes, L., Moan, J., Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr. Diab. 12:2 (2011), 120–126.
119. Zittermann, A., Vitamin D and disease prevention with special reference to cardiovascular disease. Prog. Biophys. Mol. Biol. 92:1 (2006), 39–48.
120. Mathieu, C., Gysemans, C., Giulietti, A., Bouillon, R., Vitamin D and diabetes. Diabetologia 48:7 (2005), 1247–1257.
121. Ducloux, R., Nobecourt, E., Chevallier, J.M., Ducloux, H., Elian, N., Altman, J.J., Vitamin D deficiency before bariatric surgery: should supplement intake be routinely prescribed?. Obes. Surg. 21:5 (2011), 556–560.
122. Pittas, A.G., Lau, J., Hu, F.B., Dawson-Hughes, B., The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92:6 (2007), 2017–2029.
123. Baz-Hecht, M., Goldfine, A.B., The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr. Opin. Endocrinol. Diab. Obes. 17:2 (2010), 113–119.
124. Bener, A., Al-Hamaq, A.O., Kurtulus, E.M., Abdullatef, W.K., Zirie, M., The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients. Diab. Metab. Syndr., 2016.
125. Elamin, M.B., Abu Elnour, N.O., Elamin, K.B., Fatourechi, M.M., Alkatib, A.A., Almandoz, J.P., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96:7 (2011), 1931–1942.
126. Jorde, R., Sneve, M., Emaus, N., Figenschau, Y., Grimnes, G., Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur. J. Nutr. 49:7 (2010), 401–407.
127. Pittas, A.G., Harris, S.S., Stark, P.C., Dawson-Hughes, B., The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diab. Care 30:4 (2007), 980–986.
128. Lind, L., Lithell, H., Skarfors, E., Wide, L., Ljunghall, S., Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med. Scand. 223:3 (1988), 211–217.
129. Lach, K., Krajewski-Siuda, K., Vitamin D3 in prevention of diseases in adults-a systematic review. Wiad. Lek. 63:4 (2010), 316–330.
130. Schottker, B., Herder, C., Rothenbacher, D., Perna, L., Muller, H., Brenner, H., Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur. J. Epidemiol. 28:3 (2013), 267–275.
131. Pittas, A.G., Sun, Q., Manson, J.E., Dawson-Hughes, B., Hu, F.B., Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diab. Care 33:9 (2010), 2021–2023.
132. Mattila, C., Knekt, P., Mannisto, S., Rissanen, H., Laaksonen, M.A., Montonen, J., et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diab. Care 30:10 (2007), 2569–2570.
133. Gagnon, C., Lu, Z.X., Magliano, D.J., Dunstan, D.W., Shaw, J.E., Zimmet, P.Z., et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diab. Care 34:5 (2011), 1133–1138.
134. Gupta, A.K., Brashear, M.M., Johnson, W.D., Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diab. Care 34:3 (2011), 658–660.
135. Clemente-Postigo, M., Munoz-Garach, A., Serrano, M., Garrido-Sanchez, L., Bernal-Lopez, M.R., Fernandez-Garcia, D., et al. Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J. Clin. Endocrinol. Metab. 100:4 (2015), E591–5.
136. Gagnon, C., Daly, R.M., Carpentier, A., Lu, Z.X., Shore-Lorenti, C., Sikaris, K., et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One, 9(10), 2014, e109607.
137. Jehle, S., Lardi, A., Felix, B., Hulter, H.N., Stettler, C., Krapf, R., Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study. Swiss Med. Wkly., 144, 2014, w13942.
138. Sabherwal, S., Bravis, V., Devendra, D., Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int. J. Clin. Pract. 64:8 (2010), 1084–1089.
139. Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57:10 (2014), 2038–2047.
140. Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium plus vitamin d supplementation on anthropometric measurements and blood pressure in Vitamin D insufficient people with type 2 diabetes: a randomized controlled clinical trial. J. Am. Coll. Nutr. 34:4 (2015), 281–289.
141. Carnevale, V., Inglese, M., Annese, M.A., De Matthaeis, A., Santini, S.A., Frusciante, V., et al. Vitamin D and parameters of calcium homeostasis in inpatients with and without Type 2 diabetes mellitus. J. Endocrinol. Invest. 35:9 (2012), 853–858.
142. de Boer, I.H., Tinker, L.F., Connelly, S., Curb, J.D., Howard, B.V., Kestenbaum, B., et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diab. Care 31:4 (2008), 701–707.
143. Robinson, J.G., Manson, J.E., Larson, J., Liu, S., Song, Y., Howard, B.V., et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diab. Care 34:3 (2011), 628–634.
144. Chacko, S.A., Song, Y., Manson, J.E., Van Horn, L., Eaton, C., Martin, L.W., et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am. J. Clin. Nutr. 94:1 (2011), 209–217.
145. Cheng, T.Y., Millen, A.E., Wactawski-Wende, J., Beresford, S.A., LaCroix, A.Z., Zheng, Y., et al. Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. J. Nutr. 144:5 (2014), 681–689.
146. Radford, L.T., Bolland, M.J., Gamble, G.D., Grey, A., Reid, I.R., Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey. Rep., 2, 2013, 293.
147. Driver, J.P., Lamont, D.J., Gysemans, C., Mathieu, C., Serreze, D.V., Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. Endocrinology 152:12 (2011), 4620–4629.
148. Mitri, J., Dawson-Hughes, B., Hu, F.B., Pittas, A.G., Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94:2 (2011), 486–494.
149. George, N., Kumar, T.P., Antony, S., Jayanarayanan, S., Paulose, C.S., Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br. J. Nutr. 108:8 (2012), 1410–1418.
150. Pittas, A.G., Dawson-Hughes, B., Li, T., Van Dam, R.M., Willett, W.C., Manson, J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diab. Care 29:3 (2006), 650–656.
151. Nunlee-Bland, G., Gambhir, K., Abrams, C., Abdul, M., Vahedi, M., Odonkor, W., Vitamin D deficiency and insulin resistance in obese African-American adolescents. J. Pediatr. Endocrinol. Metab. 24:1–2 (2011), 29–33.
152. Rajakumar, K., de las Heras, J., Chen, T.C., Lee, S., Holick, M.F., Arslanian, S.A., Vitamin D status, adiposity, and lipids in black American and Caucasian children. J. Clin. Endocrinol. Metab. 96:5 (2011), 1560–1567.
153. Gilbert-Diamond, D., Baylin, A., Mora-Plazas, M., Marin, C., Arsenault, J.E., Hughes, M.D., et al. Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study. Am. J. Clin. Nutr. 92:6 (2010), 1446–1451.
154. Ford, E.S., Zhao, G., Tsai, J., Li, C., Associations between concentrations of vitamin D and concentrations of insulin, glucose, and HbA1c among adolescents in the United States. Diab. Care 34:3 (2011), 646–648.
155. Majumdar, V., Nagaraja, D., Christopher, R., Vitamin D status and metabolic syndrome in Asian Indians. Int. J. Obes. (Lond.) 35:8 (2011), 1131–1134.
156. Yetley, E.A., Assessing the vitamin D status of the US population. Am. J. Clin. Nutr. 88:2 (2008), 558S–564S.
157. Reddy Vanga, S., Good, M., Howard, P.A., Vacek, J.L., Role of vitamin D in cardiovascular health. Am. J. Cardiol. 106:6 (2010), 798–805.
158. Tzotzas, T., Papadopoulou, F.G., Tziomalos, K., Karras, S., Gastaris, K., Perros, P., et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J. Clin. Endocrinol. Metab. 95:9 (2010), 4251–4257.
159. Caron-Jobin, M., Morisset, A.S., Tremblay, A., Huot, C., Legare, D., Tchernof, A., Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring) 19:7 (2011), 1335–1341.
160. Liu, S., Song, Y., Ford, E.S., Manson, J.E., Buring, J.E., Ridker, P.M., Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diab. Care 28:12 (2005), 2926–2932.
161. Kremer, R., Campbell, P.P., Reinhardt, T., Gilsanz, V., Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J. Clin. Endocrinol. Metab. 94:1 (2009), 67–73.
162. von Hurst, P.R., Stonehouse, W., Matthys, C., Conlon, C., Kruger, M.C., Coad, J., Study protocol-metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health, 8, 2008, 267.
163. Suzuki, A., Kotake, M., Ono, Y., Kato, T., Oda, N., Hayakawa, N., et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr. J. 53:4 (2006), 503–510.
164. Blanton, D., Han, Z., Bierschenk, L., Linga-Reddy, M.V., Wang, H., Clare-Salzler, M., et al. Reduced serum Vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes, 2011.
165. Devaraj, S., Jialal, G., Cook, T., Siegel, D., Jialal, I., Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm. Metab. Res. 43:1 (2011), 72–74.
166. Janisse, H.C., Cakan, N., Ellis, D., Brogan, K., Dietary vitamin D intake among high-risk adolescents with insulin dependent diabetes. Diab. Educ. 37:2 (2011), 222–226.
167. Maxwell, C.S., Wood, R.J., Update on vitamin D and type 2 diabetes. Nutr. Rev. 69:5 (2011), 291–295.
168. Bone, Vestergaard P., Vitamin D to prevent fractures-current data create confusion. Nat. Rev. Endocrinol. 8:10 (2012), 569–570.
169. Velasco, S., Jamal, S.A., Nutrition: calcium and vitamin D for extraskeletal health-jury is out. Nat. Rev. Endocrinol. 8:3 (2012), 132–133.
170. Nigil Haroon, N., Anton, A., John, J., Mittal, M., Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies. J. Diab. Metab. Disord., 14, 2015, 3.
171. Zipitis, C.S., Akobeng, A.K., Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93:6 (2008), 512–517.
172. Dong, J.Y., Zhang, W.G., Chen, J.J., Zhang, Z.L., Han, S.F., Qin, L.Q., Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 5:9 (2013), 3551–3562.
173. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. the EURODIAB substudy 2 study group. Diabetologia 42:1 (1999), 51–54.
174. Ford, E.S., Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am. J. Epidemiol. 153:9 (2001), 892–897.
175. Brekke, H.K., Ludvigsson, J., Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr. Diab. 8:1 (2007), 11–14.
176. Looker, A.C., Lacher, D.A., Pfeiffer, C.M., Schleicher, R.L., Picciano, M.F., Yetley, E.A., Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. Am. J. Clin. Nutr., 90(3), 2009, 695.
177. Looker, A.C., Pfeiffer, C.M., Lacher, D.A., Schleicher, R.L., Picciano, M.F., Yetley, E.A., Serum 25-hydroxyvitamin d status of the US population: 1988–1994 compared with 2000–2004. Am. J. Clin. Nutr. 88:6 (2008), 1519–1527.
178. Langlois, K., Greene-Finestone, L., Little, J., Hidiroglou, N., Whiting, S., Vitamin D status of canadians as measured in the 2007 to 2009 Canadian health measures survey. Health Rep. 21:1 (2010), 47–55.
179. Berger, C., Greene-Finestone, L.S., Langsetmo, L., Kreiger, N., Joseph, L., Kovacs, C.S., et al. Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J. Bone Miner. Res. 27:6 (2012), 1381–1389.
180. Shi, H., Norman, A.W., Okamura, W.H., Sen, A., Zemel, M.B., 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 15:14 (2001), 2751–2753.
181. DeLuca, H.F., Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80:Suppl. 6 (2004), 96S–1689S.
182. Holick, M.F., Vitamin D deficiency. N. Engl. J. Med. 357:3 (2007), 266–281.
183. Aloia, J.F., African americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am. J. Clin. Nutr. 88:2 (2008), 545S–550S.
184. Arunabh, S., Pollack, S., Yeh, J., Aloia, J.F., Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 88:1 (2003), 157–161.
185. Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z., Holick, M.F., Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 72:3 (2000), 690–693.
186. Shafinaz, I.S., Moy, F.M., Vitamin D level and its association with adiposity among multi-ethnic adults in Kuala Lumpur, Malaysia: a cross sectional study. BMC Public Health, 16, 2016, 232.
187. Karlsson, T., Andersson, L., Hussain, A., Bosaeus, M., Jansson, N., Osmancevic, A., et al. Lower vitamin D status in obese compared with normal-weight women despite higher vitamin D intake in early pregnancy. Clin. Nutr. 34:5 (2015), 892–898.
188. Palacios, C., Gil, K., Perez, C.M., Joshipura, K., Determinants of vitamin D status among overweight and obese Puerto Rican adults. Ann. Nutr. Metab. 60:1 (2012), 35–43.
189. Pannu, P.K., Zhao, Y., Soares, M.J., Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr. Res. 36:3 (2016), 201–213.
190. Pourshahidi, L.K., Vitamin D and obesity: current perspectives and future directions. Proc. Nutr. Soc. 74:2 (2015), 115–124.
191. Aridi, H.D., Alami, R.S., Fouani, T., Shamseddine, G., Tamim, H., Safadi, B., Prevalence of vitamin D deficiency in adults presenting for bariatric surgery in Lebanon. Surg. Obes. Relat. Dis. 12:2 (2016), 405–411.
192. Wimalawansa, S.J., Food fortification programs to alleviate micronutrient deficiencies. J. Food Process Technol. 4:8 (2013), 257–267.
193. Censani, M., Stein, E.M., Shane, E., Oberfield, S.E., McMahon, D.J., Lerner, S., et al. Vitamin D deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery. ISRN Obes, 2013, 2013.
194. Rothkopf, M.M., Reversible neurologic dysfunction caused by severe vitamin deficiency after malabsorptive bariatric surgery. Surg. Obes. Relat. Dis. 2:6 (2006), 656–660.
195. Slater, G.H., Ren, C.J., Siegel, N., Williams, T., Barr, D., Wolfe, B., et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J. Gastrointest. Surg. 8:1 (2004), 48–55 discussion 4–5.
196. Ducloux, R., Janin, C., Ducloux, H., Altman, J.J., High vitamin D deficiency rate in metabolic inpatients: is bariatric surgery planning found guilty?. Obes. Surg. 24:11 (2014), 1947–1953.
197. Gemmel, K., Santry, H.P., Prachand, V.N., Alverdy, J.C., Vitamin D deficiency in preoperative bariatric surgery patients. Surg. Obes. Relat. Dis. 5:1 (2009), 54–59.
198. Altieri, B., Grant, W.B., Casa, S.D., Orio, F., Pontecorvi, A., Colao, A., et al. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer. Crit. Rev. Food Sci. Nutr., 0, 2016.
199. Zeitz, U., Weber, K., Soegiarto, D.W., Wolf, E., Balling, R., Erben, R.G., Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 17:3 (2003), 509–511.
200. Takiishi, T., Gysemans, C., Bouillon, R., Mathieu, C., Vitamin, D., Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 39:2 (2010), 419–446 table of contents.
201. Shankar, A., Sabanayagam, C., Kalidindi, S., Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diab. Care 34:5 (2011), 1114–1119.
202. Wehr, E., Pilz, S., Schweighofer, N., Giuliani, A., Kopera, D., Pieber, T.R., et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur. J. Endocrinol. 161:4 (2009), 575–582.
203. Harris, S.S., Vitamin D in type 1 diabetes prevention. J. Nutr. 135:2 (2005), 323–325.
204. Caramaschi, P., Dalla Gassa, A., Ruzzenente, O., Volpe, A., Ravagnani, V., Tinazzi, I., et al. Vitamin D and autoimmune rheumatic diseases. Clin. Rheumatol. 30:3 (2011), 443–444.
205. Cherniack, E.P., A ray of hope for tender joints: vitamin D and rheumatoid arthritis. J. Rheumatol. 38:1 (2011), 5–7.
206. Cutolo, M., Pizzorni, C., Sulli, A., Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev., 2011.
207. Tripkovic, L., Lambert, H., Hart, K., Smith, C.P., Bucca, G., Penson, S., et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am. J. Clin. Nutr. 95:6 (2012), 1357–1364.
208. Daroux, M., Shenouda, M., Bacri, J.L., Lemaitre, V., Vanhille, P., Bataille, P., Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study. J. Nephrol., 0, 2012.
209. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. 1997. In: Medicine Io, ed. Washington, DC : Food and Nutrition Board.
210. Continuing Survey of Food Intakes by Individuals (CSFn): diet and health knowledge survey 1991. In: Agriculture USDo, ed. Springfield, VA: U.S. Department of Commerce, National Technical Information Service; 1994:(PB94500063: machine readable data set).
211. Basha, B., Rao, D.S., Han, Z.H., Parfitt, A.M., Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am. J. Med. 108:4 (2000), 296–300.
212. Institute of Medicine 2010; Pages. Accessed at Food and Nutrition Board at http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx.
213. Smith, G., Wimalawansa, S.J., Reconciling the irreconcilable: micronutrients in clinical nutrition and public health. Vitam. Miner. 4:1 (2015), 1–4.
214. Baggerly, C.A., Cuomo, R.E., French, C.B., Garland, C.F., Gorham, E.D., Grant, W.B., et al. Sunlight and Vitamin D: necessary for public health. J. Am. Coll. Nutr. 34:4 (2015), 359–365.
215. 2010; Pages. Accessed at Harvard School of Public Health Nutrition Source at www.hsph.harvard.edu/nutritionsource/what-should-you-eat/vitamin-d/index.html.
216. Mohr, S.B., Garland, C.F., Gorham, E.D., Garland, F.C., The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:8 (2008), 1391–1398.
217. Kahn, S.E., Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 86:9 (2001), 4047–4058.
218. Ludwig, D.S., The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:18 (2002), 2414–2423.